Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta de Hierro (16)

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

2023

  1. Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 18, pp. 2277-2290

  2. Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience

    Circulation: Cardiovascular Interventions, Vol. 16, Núm. 3, pp. E012554

2022

  1. Frailty and prognosis of older patients with chronic heart failure

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019

  2. Sex differences in the impact of frailty in elderly outpatients with heart failure

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427

2021

  1. Age and Gender influence on time of arrival for STEMI patients during Covid-19 pandemic

    American Journal of Emergency Medicine

  2. Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement

    Journal of the American Heart Association, Vol. 10, Núm. 12

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2016

  1. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 67, Núm. 23, pp. 2705-2715

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  2. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386

2013

  1. Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)

    American Journal of Cardiology, Vol. 111, Núm. 5, pp. 676-683

  2. Mortalidad intrahospitalaria por infarto agudo de miocardio. Relevancia del tipo de hospital y la atención dispensada. Estudio RECALCAR

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 935-942

2010

  1. Response to letter regarding article, "assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: Validation with endomyocardial sampling in cardiac allografts"

    Circulation